• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Peter Aran on How to Improve Quality Measure Decisions

Video

New approaches for measuring quality need to be developed to get frontline caregivers involved in the early stages of quality measure decisions, said Peter Aran, MD, medical director of population health management at Blue Cross Blue Shield of Oklahoma.

New approaches for measuring quality need to be developed to get frontline caregivers involved in the early stages of quality measure decisions, said Peter Aran, MD, medical director of population health management at Blue Cross Blue Shield of Oklahoma.

Transcript

How can we avoid the physician burden of duplicate quality reporting?

Part of the quadruple aim model that we’re trying to follow is that you ask the practices: what quality metrics or measures do they think we should use? Also, if their own family were being taken care of, what kinds of things would they want to know are being done for their parents, or sisters, or kids? So, having the practices themselves weigh in and help decide which quality measures to use is the better way to go.

Right now, most initiatives, as you know, are figured out or designed by big groups, whether it’s CMS, or whether it’s large insurance companies, or a consortia of academic centers. Then, they’re given to the docs and the docs say take this and run with it. We think another approach, a better approach is you include those docs, the frontline caregivers, earlier upstream and say: help us design this initiative, help us decide which quality measures to use.

Related Videos
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center.
Debra Boyer, MD, MHPE, ATSF.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.